These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8038898)

  • 1. Protein levels and plasmapheresis intensity.
    Ciszewski TS; Ralston S; Acteson D; Wasi S; Strong SJ
    Transfus Med; 1993 Mar; 3(1):59-65. PubMed ID: 8038898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum IgG and IgM levels in new and regular long-term plasmapheresis donors.
    Burgin M; Hopkins G; Moore B; Nasser J; Richardson A; Minchinton R
    Med Lab Sci; 1992 Dec; 49(4):265-70. PubMed ID: 1339930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term and long-term effects of plasmapheresis on serum proteins and immunoglobulins.
    Friedman BA; Schork MA; Mocniak JL; Oberman HA
    Transfusion; 1975; 15(5):467-72. PubMed ID: 53919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Canadian Red Cross plasmapheresis donor safety program: changes in plasma proteins after long-term plasmapheresis.
    Wasi S; Santowski T; Murray SA; Perrault RA; Gill P
    Vox Sang; 1991; 60(2):82-7. PubMed ID: 2031342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of different intensities of regular donor plasmapheresis on humoral and cellular immunity, red cell and iron metabolism, and cardiovascular risk markers.
    Tran-Mi B; Storch H; Seidel K; Schulzki T; Haubelt H; Anders C; Nagel D; Siegler KE; Vogt A; Seiler D; Hellstern P
    Vox Sang; 2004 Apr; 86(3):189-97. PubMed ID: 15078254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Serum levels of IgG, IgA, IgM, blood proteins and various lysosomal enzymes in donors after repeated plasmapheresis].
    Chocha A; Nenycz A; Szklarska W
    Wiad Lek; 1990 Oct 1-15; 43(19-20):949-52. PubMed ID: 2127490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effect of plasmapheresis on IgG and albumin].
    Flesland O; Halvorsen R; Solheim BG; Orjasaeter H
    Tidsskr Nor Laegeforen; 1990 Jun; 110(15):1936-7. PubMed ID: 2363163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective multicentre study on the safety of long-term intensive plasmapheresis in donors (SIPLA).
    Schulzki T; Seidel K; Storch H; Karges H; Kiessig S; Schneider S; Taborski U; Wolter K; Steppat D; Behm E; Zeisner M; Hellstern P;
    Vox Sang; 2006 Aug; 91(2):162-73. PubMed ID: 16907878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum immunoglobulin levels during contraceptive use of depot-medroxyprogesterone acetate in Indian women: a preliminary study.
    Lali P; Chandra L; Gupta RP
    Contraception; 1996 Jun; 53(6):363-5. PubMed ID: 8773424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and persistence of West Nile virus-specific immunoglobulin M (IgM), IgA, and IgG in viremic blood donors.
    Prince HE; Tobler LH; Lapé-Nixon M; Foster GA; Stramer SL; Busch MP
    J Clin Microbiol; 2005 Sep; 43(9):4316-20. PubMed ID: 16145071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Observation of the changes of plasma proteins after long term plasmapheresis.
    Grgicević D; Pistotnik M; Pende B
    Dev Biol Stand; 1980; 48():279-86. PubMed ID: 6168506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoglobulin G levels during collection of large volume plasma for fractionation.
    Burkhardt T; Rothe R; Moog R
    Transfus Apher Sci; 2017 Jun; 56(3):417-420. PubMed ID: 28454884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. More selective removal of myeloperoxidase-anti-neutrophil cytoplasmic antibody from the circulation of patients with vasculitides using a novel double-filtration plasmapheresis therapy.
    Gong D; Ji D; Xu B; Liu Z
    Ther Apher Dial; 2013 Feb; 17(1):93-8. PubMed ID: 23379500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum concentrations of IgG, IgA, and IgM in retired racing Greyhound dogs.
    Clemente M; Marín L; Iazbik MC; Couto CG
    Vet Clin Pathol; 2010 Dec; 39(4):436-9. PubMed ID: 21198733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective trial on the safety of long-term intensive plasmapheresis in donors.
    Bechtloff S; Tran-My B; Haubelt H; Stelzer G; Anders C; Hellstern P
    Vox Sang; 2005 Apr; 88(3):189-95. PubMed ID: 15787729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of the prevalence of human parvovirus B19 DNA in Korean plasmapheresis donors.
    Oh DJ; Lee YL; Kang JW; Kwon SY; Cho NS
    Korean J Lab Med; 2010 Feb; 30(1):58-64. PubMed ID: 20197724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current plasmapheresis practice in the United States.
    Tullis JL
    Ric Clin Lab; 1983; 13(1):11-9. PubMed ID: 6344176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of donation frequency on donor health in blood donors donating plasma by plasmapheresis: study protocol for a randomized controlled trial.
    Haugen M; Magnussen K; Aarsland TE; Nissen-Meyer LSH; Strand TA
    Trials; 2024 Mar; 25(1):175. PubMed ID: 38468338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of frequency donations of plasma standard dose on immune reactivity of regular donors].
    Iavorskyĭ VV
    Klin Khir; 2013 Aug; (8):65-8. PubMed ID: 24171294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Changes of IgA, IgG and IgM immunoglobulins and of 10 other plasma proteins in patients with duodenal ulcer treated with ranitidine].
    Przybyłowski J; Bartelik S; Szrajer J; Kolus D
    Wiad Lek; 1993; 46(1-2):9-13. PubMed ID: 8249388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.